Gender-specific nonrandom association between the α1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease

Genetic Epidemiology

Volumn 14, Issue 2, 1997, Pages 169-180

  Kamboh, M Ilyas ^a   Sanghera, Dharambir K ^a   Aston, Christopher E ^a   Bunker, Clareann H ^a   Hamman, Richard F ^c   Ferrell, Robert E ^a   Dekosky, Steven T ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; APOE; Caucasians; interaction; Nigerian Blacks; 1 antichymotrypsin

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; FEMALE; GENDER; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; RISK FACTOR;

EID: 0030990160     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(1997)14:2<169::AID-GEPI6>3.0.CO;2-2     Document Type: Article

References (26)

1. Aronson MK, Ooi WL, Morgenstern H, Hafner A, Masur D, Crystal H, Frishman WH, Fisher D, Katzman R (1990):Women, myocardial infarction and dementia in the very old. Neurology 40:1102-1106.
2. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D'Agostino RB, White LR (1992):Prevalence of dementia and probable senile dementia of Alzheimer type in the Framingham study. Neurology 42:115-119.
3. Bunker CH, Ukoli FA, Matthews KA, Kriska AM, Houston SL, Kuller LH (1995):Weight threshold and blood pressure in a lean Black population. Hypertension 26:616-623.
4. Cauley J, Eichner JE, Kamboh MI, Ferrell RE, Kuller LH, Black DM (1993):ApoE allele frequencies in younger (age 42-50) vs. older (age 65-90) women. Genet Epidemiol 10:27-34.
5. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993):Gene dosage of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
6. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locker PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1994):Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Na Genet 7:180-183.
7. Davignon J, Bouthillier D, Nestruck A, Sing C (1988):Apolipoprotein E polymorphism and atherosclerosis:Insight from a study in octogenarians. Trans Am Clin Climatol Assoc 99:100-110.
8. Hamman RE, Marshall JA, Baxter J, Kahn LR, Mayer EJ, Orleans M, Murphy JR, Lezotte DC (1989):Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population:The San Luis Valley Diabetes Study. Am J Epidemiol 129:295-311.
9. Hendrie HC, Hall KS, Hui S, Unverzagt FW, Yu CE, Lahiri KD, Sahota A, Farlow M, Musick B, Class CA, Grashear A, Burdine VE, Osuntokun BO, Ogunniyi AO, Gureje O, Baiyewn O, Schellenberg GD (1995):Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 37:118-120.
10. Hixson JE, Patholigical Determinants of Atherosclerosis in Youth (PDAY) Research Group (1991):Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb 11:1237-1244.
11. Hyman BT, West HL, Rebeck GW, Buldyrev SV, Mantegna RN, Ukleja M, Havlin S, Stanley HE (1995):Quantitative analysis of senile plaques in Alzheimer's disease:Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci USA 92:3586-3590.
12. Kamboh MI (1995):Apolipoprotein E polymorphism and susceptibility to AJzbeimer's disease. Hum Biol 67:195-215.
13. Kamboh MI, Sanghere DK, Ferrell RE, DeKosky ST (1995a):APOE*4-associated Alzheimer's disease risk is modified by al-antichymotrypsin polymorphism. Na Genet 10:486-488.
14. Kamboh MI, Aston CE, Hamman RF (1995b):The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic individuals in a biethnic population from the San Luis Valley. Colorado. Atherosclerosis 112:145-159.
15. Ma J, Yee A, Brewer HB Jr, Das S, Potter H (1994):Amyloid associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372:92-94.
16. Maestre G, Ottman R, Stern Y, Gurland B, Chun M, Tang M-X, Shelanski M, Tycko B, Mayeux R (1995):Apolipoprotein E and Alzheimer's disease:Ethnic variation in genotypic risk. Ann Neurol 37:254-259.
17. Osuntokun BO, Sahota A, Ogunniyi AO, Gureje O, Baiyewu O, Adeyinka A, Oluwole SO, Komolafe O, Hall KS, Unverzagt FW, Hui SL, Yang M, Hendrie HC (1995):Lack of an association between apolipoprotein E ℰ4 and Alzheimer's disease in elderly Nigerians. Ann Neurol 38:463-465.
18. Payami H, Montee K, Grimslid H, Shattnc S, Kaye T (1996a):Increased risk of familial late-onset Alzheimer's disease in women. Neurology 46:126-129.
19. Payami H, Zareparsi S, Montee KR, Sexton GJ, Kaye JA, Bird TD, Yu C-E, Wijsman EM, Heston LL, Litt M, Schellenberg GD (1996b):Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease:A possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 58:803-811.
20. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993):Apolipoprotein E in sporadic Alzheimer's disease:Allelic variation and receptor interactions. Neuron 11:575-580.
21. Rocca WA, Hofman A, Brayne C, Breteler MMB, Clark M, Copeland JRM, Dartignes J-F. Engedal K, Hagnell O, Heeren TJ, Jonker C, Lindesay J, Lobo A, Mann AH, Mölsä PK, Morgan K, O'Connor DW, da Silva Droux A, Sulkava R, Kay DWK, Amaducci L, for the EURODEM-Prevalence Research Group (1991):Frequency and distribution of Alzheimer's disease in Europe:A collaborative study of 1980-1990 prevalence findings. Ann Neurol 30:381-390.
22. Roses AD (1994):Apolipoprotein E affects the rate of Alzheimer's disease expression:β-Amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 53:429-437.
23. Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmeche D, Wisniewski T, Frangione B, Roses AD, Strittmatter WJ (1994):Apolipoprotein E associates with β-amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest 94:860-869.
24. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-Maclachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993):Association of apolipoprotein E allele ℰ4 with late onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.
25. Tang M-X, Maestre G, Tsai W-Y, Liu X-H, Feng L, Chung W-Y, Chun M, Schofield P, Stern Y, Tycko B, Mayeux R (1996):Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians and Hispanics in New York City. Am J Hum Genet 58:574-584.
26. Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B (1994):Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 145:1030-1035.